A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The trial, described in a […]
Trial
Trial shows two investigational drugs are ineffective for treating severe COVID-19
Credit: Unsplash/CC0 Public Domain Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor. Identifying new therapies for severe COVID-19 remains a high priority and one in which Vanderbilt University Medical Center is taking […]
University of Colorado School of Medicine researchers launch trial for new COVID vaccine for children
Colorado researchers launch trial for new COVID vaccine for children Colorado researchers launch trial for new COVID vaccine for children 01:43 Researchers at the University of Colorado School of Medicine are enlisting families for a new COVID vaccine trial. While many of the signs we used to see linked to […]
A promising new Covid pill shows key advantages over Paxlovid in trial
A staff member sorts medicines at a pharmacy in Huai ‘an, China on Dec. 10, 2022. CFOTO | Future Publishing | Getty Images A new antiviral pill for Covid was found to be as effective as Paxlovid at curbing mild to moderate illness among people at high risk of severe […]
Amgen, AstraZeneca say experimental asthma drug meets trial goal
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid (Reuters) – Drugmakers Amgen Inc and AstraZeneca Plc said on Tuesday a pivotal trial found that their […]
Study in Nature Medicine Shows Superior Outcomes for Patients in The Leukemia & Lymphoma Society’s Paradigm-Shifting Beat AML Clinical Trial
RYE BROOK, N.Y., Oct. 26, 2020 /PRNewswire/ — Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature […]
Study in Nature Medicine shows superior patient outcomes in LLS’s Beat AML clinical trial
Rye Brook, NY (Monday, October 26, 2020) – Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature […]
Lilly Stops Antibody Trial in Hospitalized COVID-19 Patients
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Eli Lilly announced it will halt its ACTIV-3 trial evaluating the antibody bamlanivimab in combination with remdesivir for people hospitalized with COVID-19, after new evidence regarding efficacy emerged. The new data from the National Institutes of […]